RohitDhallMD, MSPH, CPE
Neurology • Little Rock, ARMovement Disorder, Neurodegenerative, Dementia & Geriatrics
Professor and Vice Chair of Neurology, Medical Director of Clinical Trials Innovation Unit, University of Arkansas for Medical Sciences
Dr. Dhall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UAMS Medical Center
501 Jack Stephens Drive Jackson T. Stephens Spine and Neuroscience Institute, First Floor
Little Rock, AR 72205Phone+1 501-686-5838Fax+1 501-603-1539- Is this information wrong?
Education & Training
University of Alabama Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2007 - 2009- University of Alabama Medical CenterResidency, Neurology, 2004 - 2007
The University of Texas Health Science CenterMSPH, Epidemiology, 2001 - 2007
University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2003 - 2004
All India Institute of Medical SciencesClass of 2000
Certifications & Licensure
CA State Medical License 2015 - Present
TX State Medical License 2009 - 2025
AR State Medical License 2016 - 2025
FL State Medical License 2015 - 2017
AZ State Medical License 2009 - 2016
AL State Medical License Active through 2009- American Board of Psychiatry and Neurology Neurology
- American Association of Physician LeadersCertified Physician Executive
Clinical Trials
- Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders Start of enrollment: 2017 Nov 14
- Open-label Trial in Parkinson's Disease (PD) Start of enrollment: 2021 Feb 24
Roles: Contact
- Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2020 Oct 27
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.McGarry, A., Rosanbalm, S., Leinonen, M., Olanow, C., To, D., Bell, A., Lee, D., Chang, J., Dubow, J., Dhall, R., Burdick, D., Parashos, S., Feuerstein, J., Quinn, J.,...> ;The Lancet. Neurology. 2024 Jan 1
- Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.Zeitlin, L., Banisadr, G., Fisher, S., Visser, H., Espay, A., Hauser, R., Dhall, R., Thakkar, S., Cloud, L.> ;Movement Disorders. 2024 Feb 1
- A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Releas...C Warren Olanow, Robert A Hauser, Daniel J Burdick, Rohit Dhall, Joy Antonelle de Marcaida, Ramon A Gil, David L Kreitzman, Lawrence W Elmer, Andrew McGarry, Karl Kieb...> ;Movement Disorders. 2024 Feb 1
- Join now to see all
Press Mentions
Huntington’s Disease Symposium Details Resources, Seeks Study ParticipantsJanuary 20th, 2023- After Deep Brain Stimulation Surgery, Arkansas Writer’s Tremors Resume … Until Doctor Activates His ImplantsOctober 11th, 2021
- Utility of Objective Gait Measures in Levodopa‐Unresponsive Freezing in Parkinson'sJanuary 13th, 2021
- Join now to see all
Hospital Affiliations
UAMS Medical CenterLittle Rock, Arkansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
